Founded in 2022 and headquartered in Boston, Stellaromics is revolutionizing biomedical research with its proprietary technology, unraveling complex 3D transcription and translation patterns within native biological tissue. At the forefront of their innovation is STARmap (Spatially-resolved Transcript Amplicon Readout mapping), their flagship product. STARmap empowers researchers to uncover gene expression patterns within intact tissue, facilitating the pinpointing of treatment targets and bolstering biomedical investigations. Stellaromics is currently in the advanced stages of developing its Plexa™ suite of products, meticulously crafted to empower researchers and clinicians in the creation of intricate cellular maps, thereby amplifying our comprehension of various diseases. For comprehensive details, we invite you to explore our website at stellaromics.com. Join us in shaping the future of biomedical research.
Location: United States, Massachusetts, Natick
Employees: 1-10
Total raised: $105M
Founded date: 2022
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.02.2025 | Series B | $80M | - |
| 02.11.2023 | Series A | $25M | - |
Mentions in press and media 9
| Date | Title | Description |
| 16.02.2025 | Stellaromics: $80 Million (Series B) Raised For Advancing 3D Spatial Biology | Stellaromics, a pioneer in 3D spatial biology spun out of the laboratories of Karl Deisseroth (Stanford University) and Xiao Wang (MIT and Broad Institute), announced a Series B funding round of $80 million. The funding round, led by Cataly... |
| 13.02.2025 | Stellaromics: $80 Million (Series B) Raised For Advancing 3D Spatial Biology | Stellaromics, a pioneer in 3D spatial biology that spun out of the laboratories of Karl Deisseroth (Stanford University) and Xiao Wang (MIT and Broad Institute), announced today the completion of a Series B funding round at $80 million. Thi... |
| 12.02.2025 | The Future of Manufacturing: Decentralization and AI Unite | In the heart of Silicon Valley, a revolution is brewing. 3DOS, a pioneer in decentralized manufacturing, is redefining how we think about production. With the recent partnership with Walrus, a decentralized storage solution, 3DOS is not jus... |
| 11.02.2025 | Stellaromics Raises $80M in Series B Funding | Stellaromics, a Boston, MA-based 3D spatial biology company, raised $80M in Series B funding. The round was led by Catalyst4 with participation from Stanford University Ventures. The company intends to use the funds to support the developme... |
| 11.02.2025 | 3DOS Expands Decentralized Manufacturing with Walrus-Powered AI & Storage | Palo Alto, USA, February 11th, 2025, Chainwire 3DOS, the world’s first decentralized manufacturing network, has selected Walrus as its decentralized storage solution to power its expanding ecosystem of AI-driven manufacturing tools and 3D p... |
| 02.11.2023 | 3D spatial omics profiler Stellaromics scores $25M series A | A startup that aims to provide 3D views into the inner workings of tissue, ultimately charting out deep cellular maps for a better understanding of organ function and disease, is getting a big boost. Spatial multi-omics developer Stellaromi... |
| 02.11.2023 | Stellaromics Raises $25M in Series A Funding | Stellaromics, a Boston, MA-based provider of in situ spatial multi-omics technology, raised $25m in Series A financing round. Backers included Plaisance Capital Management and a private family office based in Silicon Valley. The company int... |
| - | Stellaromics | “Spatial | Stellaromics Inc” |
| - | Stellaromics: Spatial Multi-Omic Profiling Company Closes $25 Million In Funding | Stellaromics – a leading provider of in situ spatial multi-omics technology – recently announced that the company has raised $25 million in a Series A financing round. The Series A funding round included Plaisance Capital Management and a p... |